News Release 

EPA announces plan to end required animal tests for chemical safety testing

Physicians Committee for Responsible Medicine

WASHINGTON, D.C.-- The Physicians Committee for Responsible Medicine praised an Environmental Protection Agency (EPA) decision to phase out animal testing of chemical products. EPA Administrator Andrew Wheeler announced today that animal testing will be substantially reduced in six years and phased out by 2035.

The change comes after years of work by the Physicians Committee, first to pass a 2016 bill that mandated reductions in EPA animal use, and then to help regulators and product manufacturers to implement nonanimal research methods. "This measure will mean a safer environment as well as scientific methods that are technically better and more humane," said Kristie Sullivan, MPH, Physicians Committee vice president for research policy. Ms. Sullivan and Esther Haugabrooks, PhD, also of the Physicians Committee, joined Administrator Wheeler at the EPA for today's announcement .

In today's action, the EPA announced its intent to end its reliance on mammalian animal tests to assess chemical and pesticide risks and to invest in computer-based and in vitro tissue models. The EPA also announced awards of $4.2 million in grants for research into new test methods.

Currently, hundreds of thousands of animals are killed every year to test chemicals, pesticides, cleaning products, and other substances that are regulated by the EPA. Results from animal tests are often not relevant to human health, due to the significant differences across species. Additionally, tests using animals take much longer to conduct than most nonanimal methods, so new, more reliable methods will allow for the introduction of safe products on a faster timeline and will help rule out dangerous chemicals earlier.

In addition to the Physicians Committee, scientists from the People for the Ethical Treatment of Animals and the Humane Society of the United States have worked hard to replace animal use in environmental tests.

###

To speak with Ms. Sullivan, please contact Reina Pohl at 202-527-7326 or rpohl@pcrm.org.

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.